Replies to post #282010 on Innovation Pharmaceuticals Inc (IPIX)

[PJ007]

This won't be a factor if we have more than one Pharma Co competing for our science...IPIX will be in the driver's seat...LW will make it happen!!!

[djs7]

Jan 29 it was stated Locust Walk was leading negotiations for BOM.

It may well be there are multiple regional licenses in play for BOM.

This would lessen the risk for each parties trial cost and upfront payment as the cost is spread out over multiple parties.

Could allow for a decent upfront in total.

Let's wait and see how this plays out...

And who knows, after the B-UC Phase 1, maybe Locust Walk will be entering a second asset negotiation.

[CallMeCrazy]

Any "potential partner" will also understand that, even if their low ball offer is accepted, Alfasigma has the right-of-first-refusal.

This right-of-first-refusal (B-UC/CD) creates a dilemma for potential partners in that they might have to craft an offer which gives IPIX more than they'd like in order to motivate Alfasigma to refuse the offer.

Leo's first deal (B-UPS) didn't have this right-of-first-refusal feature floating in the background or Locust Walk doing the negotiating.

Message in reply to:
Lemon this is another straw against Leo in negotiating a deal. Potential partner will see how desperate he is and low ball their offer just like the first deal that he gave away at garage SALE PRICES.IMO

[TheDane]

Wow! Why didn’t I see this before? Need to follow more geniuses on the board! :-D ! Go Leo!